Kelly Malcom
Lead Research Communicator
Malcom is a lead research communicator for Michigan Medicine and research communications strategist for the U-M Medical School, with more than 20 years of experience in strategic communications, marketing, and health and science writing. She covers the basic science departments, pulmonary and critical care medicine, infectious disease, pathology and anesthesiology. Contact: [email protected]
Health Lab
COVID-19 Through the Lens of Basic Science
Watch four Michigan Medicine experts discuss the role of fundamental science in ending the COVID-19 pandemic.
Health Lab
Weakened Hearts Linked to a Build-Up of Phosphate
A computer simulation reveals the metabolic dysfunction behind heart failure.
Health Lab
High Blood Pressure Linked to Baroreflex in Rats
Animal model observation may reveal new cause of hypertension.
Health Lab
High Throughput Screening Identifies Molecules That Reduce Cellular Stress
While there is no actual fountain of youth, a new study shows a high throughput technique could help researchers find drugs that improve health and lengthen lifespan.
Health Lab
Questions and Answers About COVID-19 Vaccine Clinical Trials
Are the vaccine trials being rushed? Are they safe? Two Michigan Medicine researchers weigh in.
Health Lab
Should We Worry About COVID-19 Reinfection?
U-M expert discusses whether repeat cases of COVID-19 is bad news for vaccines.
News Release
U-M partners with NIH ACTIV Initiative for clinical trial of blood clotting treatments for COVID-19
The University of Michigan is one of several academic medical centers partnering with the National Institutes of Health on three adaptive clinical trials to evaluate the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19.
Health Lab
Antibiotic Molecule Enables Immune System to Kill HIV Infected Cells
New research shows that targeting a protein called Nef with a molecule called concanamycin A allowed the immune system to essentially cure HIV in T cells.
Health Lab
Immune Cell CXCR3 Receptor Behind Lethal Brain Damage Following Treatment for Fungal Infection
Finding could improve outcomes for treatment of infections in people living with HIV.
News Release
U-M to conduct clinical trial to test AstraZeneca COVID-19 vaccine
Michigan Medicine is partnering with the pharmaceutical company AstraZeneca for a Phase 3 clinical trial to test a vaccine against COVID-19. The AZD1222 COVID-19 VACCINE Study will research an investigational vaccine for the prevention of COVID-19, the disease caused by the new coronavirus (SARS-CoV-2).
Health Lab
Investigational New Therapy Prevents Onset of Dravet Syndrome Symptoms in Mice
Development is first step to helping children with the rare epilepsy syndrome.
Health Lab
Vaccine Q&A: From Flu to COVID-19, Everything You Need to Know
From flu shots to a vaccine for COVID-19, from herd immunity to vaccine safety, Dr. Pam Rockwell explains why vaccines are so important, especially during a pandemic.
Health Lab
Oxygen Therapy Harms Lung Microbiome in Mice
New research in mice suggests that understanding the role of the lung microbiome may be pivotal to reducing infection brought on by oxygen treatment for hypoxemia.
Health Lab
Study Reveals Transcription Factor’s Role Linking Diet and Non-Alcoholic Fatty Liver Disease
Mice lacking E4BP4 were protected against diet’s damaging effects.
Health Lab
Brain’s Ability to Rewire Itself is Connected to Gene Expression
New technique provides insight into the role of genes in brain’s plasticity and cognitive disorders.
